BCRB 2018
19/09/2018
Carbogen
carbogen
(98% O 2
/ 2% CO 2 )
ARCON phase II trial
Local control (%)
44 patients
larynx oropharynx
79 patients
hypopharynx
oral cavity
21 patients
12 patients
Time (months)
Made with FlippingBook - Online catalogs
19/09/2018
Carbogen
carbogen
(98% O 2
/ 2% CO 2 )
ARCON phase II trial
Local control (%)
44 patients
larynx oropharynx
79 patients
hypopharynx
oral cavity
21 patients
12 patients
Time (months)
Made with FlippingBook - Online catalogs